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Abstract: More than 500,000 U.S. women develop postpartum depression 
(PPD) annually. Although psychosocial risks are known, the underlying biology 
remains unclear. Dysregulation of the immune inflammatory response and the 
hypothalamic–pituitary–adrenal (HPA) axis are associated with depression in 
other populations. While significant research on the contribution of these 
systems to the development of PPD has been conducted, results have been 
inconclusive. This is partly because few studies have focused on whether 
disruption in the bidirectional and dynamic interaction between the 
inflammatory response and the HPA axis together influence PPD. In this 
study, we tested the hypothesis that disruption in the inflammatory-HPA axis 
bidirectional relationship would increase the risk of PPD. Plasma pro- and 
anti-inflammatory cytokines were measured in women during the 3rd 
trimester of pregnancy and on Days 7 and 14, and Months 1, 2, 3, and 6 after 
childbirth. Saliva was collected 5 times the day preceding blood draws for 
determination of cortisol area under the curve (AUC) and depressive 
symptoms were measured using the Edinburgh Postpartum Depression 
Survey (EPDS). Of the 152 women who completed the EPDS, 18% were 
depressed according to EDPS criteria within the 6 months postpartum. 
Cortisol AUC was higher in symptomatic women on Day 14 (p = .017). To 
consider the combined effects of cytokines and cortisol on predicting 
symptoms of PPD, a multiple logistic regression model was developed that 
included predictors identified in bivariate analyses to have an effect on 
depressive symptoms. Results indicated that family history of depression, day 
14 cortisol AUC, and the day 14 IL8/IL10 ratio were significant predictors of 
PPD symptoms. One unit increase each in the IL8/IL10 ratio and cortisol AUC 
resulted in 1.50 (p = 0.06) and 2.16 (p = 0.02) fold increases respectively in 
the development of PPD. Overall, this model correctly classified 84.2% of 
individuals in their respective groups. Findings suggest that variability in the 
complex interaction between the inflammatory response and the HPA axis 
influence the risk of PPD. 
Keywords: Postpartum depression, Inflammation, Cytokines, Cortisol, 
Cytokine–cortisol feedback circuit, Psychoneuroimmune 
1. Introduction 
Postpartum depression (PPD) is a major mood disorder 
(Association, 2013), affecting between 12% and 20% of new mothers 
(Gavin et al., 2005 and Wisner et al., 2010). PPD is characterized by 
persistent fatigue, sadness, and anxiety (Beck, 2006, Corwin et al., 
2005 and Hay et al., 2008) and carries significant and lifelong health 
consequences for women and their infants (Field, 2010). These 
consequences may be intergenerational, as infants born to mothers 
with PPD grow up to be at an increased risk of developing a mood 
disorder themselves (Hay et al., 2008 and Pearson et al., 2013). 
Although psychosocial risk factors for PPD have long been considered, 
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a growing appreciation of the mind–body connection in health and 
disease has led to an increased focus on biological risk factors that 
may underlie or contribute to the disorder. Two biological systems that 
have come under investigation as potential contributors to PPD are the 
immune-inflammatory response (Anderson and Maes, 2013, Boufidou 
et al., 2009, Corwin et al., 2008, Groer and Morgan, 2007, Maes et al., 
2000, Okun et al., 2011 and Osborne and Monk, 2013) and the 
hypothalamic–pituitary–adrenal (HPA) axis (Glynn et al., 2013, 
O’Keane et al., 2011 and Okun et al., 2011). Both undergo significant 
changes during pregnancy (Kalantaridou et al., 2010, Mastorakos and 
Ilias, 2003 and Mor and Cardenas, 2010) and both remain in flux 
during the early postpartum period (Christian and Porter, 2014, 
Hebisch et al., 2004 and Mastorakos and Ilias, 2003). 
While not an immunosuppressive state (Mor and Cardenas, 
2010), for most of pregnancy there is a shift away from a pro-
inflammatory and toward an anti-inflammatory milieu in the mother, 
protecting the fetus from rejection (Aagaard-Tillery et al., 2006). 
However, by the end of the 3rd trimester, a pro-inflammatory milieu 
again emerges (Maes et al., 2000 and Mor and Cardenas, 2010), 
playing an important role in the onset of parturition (Christiaens et al., 
2008). This pro-inflammatory response accelerates during labor, as 
most women experience some degree of pain, anxiety, stress, and 
fatigue during that time, each of which serves as a stimulus for the 
secretion of pro-inflammatory cytokines (Steptoe et al., 
2007 and Watkins et al., 1999). The inflammatory response continues 
into the postpartum period as both pro- and anti-inflammatory 
mediators drive perineal healing and uterine involution as well as 
mammary involution in women who chose to bottle feed (Chapwanya 
et al., 2012, Hojilla et al., 2011, Nilsen-Hamilton et al., 
2003 and Salamonsen, 2003). Given the association between 
inflammation and depression in non-pregnant, non-postpartum 
populations (Dantzer and Kelley, 2007 and Raison and Miller, 2013), 
more than a dozen research studies over the past two decades have 
considered exaggerated postpartum inflammation as a risk factor for 
PPD. A recent literature review, however, concluded that findings are 
inconsistent and do not allow for conclusions or generalizations to be 
made (Osborne and Monk, 2013). Limitations of prior studies include 
small sample sizes, inclusion of women with birth complications, 
limited reliability or validity of measures used to evaluate depression, 
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and samples collected at a single time, or at inconsistent times, after 
delivery. In addition, very few studies have addressed the biological 
complexity of the psychoneuroimmune (PNI) response, specifically, the 
bidirectional and dynamic interaction between the inflammatory 
response and the HPA axis. 
Like the immune system, the HPA axis is altered during 
pregnancy; by the second trimester maternal levels of serum cortisol 
are nearly double compared to levels seen in the non-pregnant state 
(Mastorakos and Ilias, 2003). Key to this scenario is the increased 
production of corticotropin-releasing hormone (CRH) by the placenta 
and fetal membranes as pregnancy advances; the resultant increase in 
cortisol production from these sources is resistant to negative 
feedback, although suppression of maternal hypothalamic CRH in 
response to the high levels of circulating cortisol is intact (Kalantaridou 
et al., 2010). With delivery of the infant and expulsion of the placenta, 
maternal cortisol levels fall significantly and quickly, to within the 
upper normal range (Chrousos et al., 1998). Maternal postpartum CRH 
suppression, however, has been hypothesized to continue for a 
variable period of time (Kalantaridou et al., 2010, Mastorakos and 
Ilias, 2003 and Vitoratos et al., 2006). A growing body of evidence 
suggests that the abrupt fall in cortisol levels and postpartum HPA axis 
suppression contribute to postpartum mood disorders (Bloch et al., 
2005, Chrousos et al., 1998, Glynn et al., 2013, Kalantaridou et al., 
2010, O’Keane et al., 2011 and Yim et al., 2009). Hyper- and hypo-
secretion of cortisol, and CRH deficiency have been linked to 
depression in non-pregnant and non-postpartum individuals as well 
(Charmandari et al., 2005, Chrousos, 1995 and Tsigos and Chrousos, 
2002). 
In addition to their individual effects, the pro-inflammatory 
response and the HPA axis exhibit significant bidirectional interactions 
via the well-documented cytokine–glucocorticoid feedback circuit 
(Besedovsky and del Rey, 1996, Elenkov, 2008 and Elenkov et al., 
2005). In this circuit, an infectious or potentially injurious stressor 
increases production of pro-inflammatory cytokines, which in turn 
activate the HPA axis, increasing cortisol secretion. Rising cortisol 
levels then bind to glucocorticoid receptors, including white blood cell 
glucocorticoid receptors (Pace and Miller, 2009), ultimately turning off 
further transcription of pro-inflammatory cytokines such as interleukin-
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10 (IL-10). The net effect of this feedback circuit is to alert the central 
nervous system to the risk of an infectious or injurious stressor, while 
at the same time limiting a potentially damaging or prolonged pro-
inflammatory response and constraining further cortisol secretion. If 
this circuit is disrupted, the ability of cortisol to limit inflammation may 
be lost (Miller et al., 1999, Miller et al., 2002, Miller et al., 2008, Miller 
et al., 2009 and Pace et al., 2012), leading to dysregulation of both 
cytokine production and cortisol secretion (Corwin et al., 2013). Nearly 
two decades ago, Chrousos and Tsigos suggested that disruption in the 
HPA axis-immune system bidirectional relationship could increase 
susceptibility to PPD (Chrousos, 1995 and Tsigos and Chrousos, 2002). 
To our knowledge, this hypothesis has not yet been tested. 
1.1. Research question 
The inflammatory immune system and the HPA axis function in 
a complex, inter-dependent manner over time to maintain baseline 
and stress-related homeostasis. Abnormal inflammation or 
dysregulation of the HPA axis has the potential to disrupt the 
relationship, carrying adverse consequences for mental and physical 
health. In light of the significant inflammatory and HPA axis changes 
following labor and delivery, and the known associations between 
depression, inflammation, and abnormal HPA axis activity in other 
populations (Anisman and Merali, 2003 and Raison et al., 2006), we 
tested the hypothesis that dysregulation in the bidirectional 
relationship between inflammation and the HPA axis early in the 
postpartum period would be associated with an increased risk of PPD 
in otherwise healthy women. 
2. Materials & methods 
2.1. Procedure 
Procedures were described in detail in a previous report 
identifying a pattern of glucocorticoid resistance in the 3rd trimester of 
pregnancy in the minority and low-income women enrolled in this 
study (Corwin et al., 2013). Briefly, women who responded to ads 
placed in community and clinic sites were recruited in their 2nd or 
early 3rd trimester of pregnancy. Following a screening interview, 
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those meeting inclusion criteria were visited at home by a registered 
nurse a total of 7 times for data collection; once between 32 and 
36 weeks of pregnancy and again at weeks one and two, and months 
1, 2, 3, and 6 after delivery. At the prenatal home visit, participants 
reviewed with the nurse the study protocol and provided informed 
consent for their participation. Participants next completed a 
demographic questionnaire providing information on age, marital 
status, race/ethnicity, personal and family history of depression, and 
whether or not they received government assistance through the 
Women, Infants, and Children (WIC) assistance program. Self-report 
of height, and pre-pregnancy weight was used for determination of 
pre-pregnancy body mass index (BMI). At this visit and at all 
subsequent home visits, women also completed questionnaires on 
current health status and on the presence of depressive symptoms via 
completion of the Edinburgh Postnatal Depression Scale (EPDS) (Cox 
et al., 1987) and perceived stress. Any subject scoring high (⩾10) on 
the EPDS or answered positively on the self-harm question were 
interviewed by the nurse and the psychiatric provider for any needed 
referrals or immediate intervention. 
After completing all self-report tools, blood was drawn from the 
antecubital vein into EDTA-containing tubes for later measurement of 
plasma pro-inflammatory cytokines released as part of the innate 
immune response and implicated in depression (Anisman and Merali, 
2003 and Raison et al., 2006), including interleukin-6 (IL-6), 
interleukin-1-beta (IL-1β), tumor necrosis factor-alpha (TNF-α), 
interleukin-8 (IL-8) and interferon-gamma (IFN-γ). Because the 
inflammatory response is regulated by the concurrent production of 
anti-inflammatory cytokines, (Petrovsky, 2001), we also measured the 
anti-inflammatory cytokine interleukin-10 (IL-10). In addition, during 
the day prior to each home visit, subjects collected a saliva sample 
upon awakening, 30-min after awakening, at 11:00 AM, 4:00 PM, and 
8:00 PM. Home visits lasted approximately 30-min. At the end of each 
home visit, women were compensated for participating and the next 
home visit was arranged. All methods employed to improve the 
accuracy and compliance of the home saliva collections (e.g., phone 
calls prior to each sample collection, the use of Medication Event 
Monitoring System [MEMS®], Aprex Corp., Fremont, Calif.)] caps, and 
reimbursement for accurate collections have been described previously 
(Corwin et al., 2013). 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Brain, Behavior, and Immunity, Vol 49 (October 2015): pg. 86-93. DOI. This article is © Elsevier and permission has been 
granted for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be 
further copied/distributed or hosted elsewhere without the express permission from Elsevier. 
7 
 
2.2. Inclusion/exclusion criteria 
Prenatal inclusion criteria were that all women were between 18 
and 40 years of age, less than 36-weeks pregnant, non-smokers, and 
anticipating the vaginal birth of a singleton infant. Additionally, women 
were required to be without pregnancy restrictions, free of any known 
chronic illness, and, with the exception of prenatal vitamins, not taking 
any over-the-counter or prescribed medications or herbs including 
anti-inflammatory or anti-depressant agents. Postnatal criteria for 
continued inclusion were that women delivered a live infant via a 
vaginal birth, without experiencing hemorrhage or transfusion, and 
that both mother and infant left the hospital together within 72-h of 
delivery. These inclusion/exclusion criteria were established to reduce 
to the extent possible prenatal or postnatal conditions that might 
themselves be associated with inflammation and/or depressed mood. 
Subjects also were required to be without symptoms of infection at the 
time of each home visit (or the visit was rescheduled) and to live 
within a 20 miles of the laboratory, to minimize the time biological 
samples were in transport. Postpartum visits at 1- and 2-weeks were 
scheduled ±48-h, while the 1-, 2-, 3-, and 6-month visits were 
scheduled ±1 week. 
2.3. Measures 
The 10-item EPDS was used for self-report of depressive 
symptoms (Cox et al., 1987). It is an effective and easy to administer 
screening tool that has been validated for both antepartum and 
postpartum use. Answers to questions such as “I have looked forward 
with enjoyment to things” are scored from 0 (“As much as I ever did”) 
to 4 (“Hardly at all”). After completion, a woman’s score is summed to 
provide information on the likelihood of clinical depression. Validation 
of the EPDS against a diagnostic clinical interview identified a 
specificity of 78%, a sensitivity of 86%, and a positive predictive value 
of 73% for women scoring >10. Although a cut-point of >9 on the 
EPDS during the first weeks postpartum has more recently been shown 
to increase the specificity of the tool (Chaudron et al., 
2010 and Teissedre and Chabrol, 2004), we retained the traditional 
cut-point since we were following participants through 6-months 
postpartum where the cut-point recommendations are higher. 
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The 14-item Perceived Stress Scale (PSS) was used to provide 
information on participants’ perception of stress (Cohen et al., 1983). 
The responses are based on a Likert-scale from 0 to 4, or from ‘‘never” 
to ‘‘very often”. Each question asks the individual how she has been 
feeling during the past month. The final score is a simple sum of each 
item response, with some items reverse coded. In Cohen’s original 
report, internal consistency reliability was high (Cronbach’s alpha 
coefficients ranged from 0.84 to 0.86) as was test–retest correlation 
(0.85). Evidence for concurrent and predictive validity was significant 
at p < 0.05 (r = 0.49). Scores on the PSS have been shown to 
correlate with measures of HPA axis function during pregnancy and the 
post-partum period (Ruiz et al., 2003) and with depressive symptoms 
(Shelton et al., 2014). 
2.4. Biomarkers 
Upon reaching the laboratory, blood samples were centrifuged 
at 4 °C for 8 min at 2000 rpm. Plasma aliquots were placed into 1.5 cc 
polypropylene microtubes and stored in the study lab at −80 °C, until 
assayed using a Human Pro-inflammatory Ultra-Sensitive assay and 
quantitative multiplex array technology (Meso Scale Discovery, 
Gaithersburg, Maryland). All samples were measured in duplicate. 
Intra-assay coefficient of variation was <5% and inter-assay 
coefficient of variation was <10%. Cytokine concentrations are 
reported individually and, since reciprocal interactions between pro- 
and anti-inflammatory cytokines finely tune the immune response 
(Petrovsky and Harrison, 1997) and may best predict the risk for 
depression in some clinical populations (Guilbaud et al., 
2009 and Taraz et al., 2012), the ratio of each pro-inflammatory 
cytokine to anti-inflammatory cytokine (e.g., IL-6/IL-10) was 
measured as well and considered in analyses. 
Saliva samples were centrifuged at 4 °C for 3 min at 2000 rpm 
after which they were aliquoted into 1.5 cc polypropylene microtubes 
for storage at −80 °C until assayed using an expanded range high 
sensitivity EIA kit (No. 1-3002/1-3012, Salimetrics, State College, PA). 
Intra-assay coefficient of variation was 4.3% and inter-assay 
coefficient of variation was 5.2%. The area under the curve (AUC) was 
determined with respect to ground (Pruessner et al., 2003), and 
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indicates the amount of cortisol secreted over the designated time 
(μg/dL/hour). 
2.5. Statistical analysis 
For descriptive analysis of the study sample, mean (standard 
deviations) and percentages were computed for continuous and 
categorical demographics (such as age, race, marital status and 
indicator of socioeconomic status) and baseline psychosocial variables 
(prior history of depression, family history of depression, prenatal total 
EPDS). 
To compare differences in cytokine levels and their pro- to anti-
inflammatory ratios between groups of women who were symptomatic 
of PPD (>10 on the EPDS) reported anytime up to 6 months 
postpartum versus those not, independent sample Student t-tests 
were performed. Because the cytokine and cortisol data were skewed, 
natural log transformations were conducted prior to all analyses; 
tables and graphs, however, report absolute levels. Temporal 
differences in cytokine ratios (IL1β/IL10, IL6/IL10, IL8/IL10, 
IFNγ/IL10, TNFα/IL10) and cortisol AUC in women non-symptomatic or 
symptomatic of PPD were assessed at the prenatal visit and days 7 
and 14, and months 1, 2, 3 and 6 postpartum using repeated 
measures analysis. Graphical analysis was used to detect patterns in 
cytokine ratios and cortisol AUC and their interactions and identify 
time points where these were significantly different between women 
non-symptomatic and symptomatic of depressive symptoms. 
Consecutively, at time points that indicated significant differences, 
joint cytokine–cortisol relationship trends were investigated for 
groups- with and without symptoms of PPD by using multiple linear 
regression methods and significant differences in trends were 
graphically illustrated. 
Because the outcome (whether symptomatic of PPD) is binary, 
bivariate and multivariate logistic regressions were performed to 
examine the individual (unadjusted) and joint (adjusted for other 
predictors) effects of pro- to anti-inflammatory cytokine ratios, and 
cortisol on the risk of PPD in postpartum women. Particularly, the pro- 
to anti-inflammatory cytokine ratios and cortisol AUCs at days 7 and 
14 were evaluated to capture the dynamic, early postpartum milieu. 
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The multiple logistic regression model adjusted for baseline 
demographics and psychosocial characteristics that were significantly 
different across the two groups. Cortisol, cytokines, and pro- to anti-
inflammatory cytokine ratios that were identified in the analyses to 
have a theoretical or statistically significant effect on the occurrence of 
depressive symptoms in postpartum women were included. 
Statistical analysis was performed using SAS (version 9.2; SAS 
Institute, Cary, NC) and SPSS 20. All statistical tests were two-sided 
and a p value of <0.05 was considered statistically significant. 
3. Results 
3.1. Demographic data 
Two-hundred and one women were enrolled in the study during 
their 3rd trimester of pregnancy. Of this number, 49 (24%) were lost 
or discontinued from further participation either prior to or 
immediately following delivery due to the following reasons: lack of 
interest or personal reasons (n = 8); having moved out of the area 
(n = 2); ill infant unable to leave the hospital within 72-h of birth 
(n = 5); stillbirth (n = 1); development of maternal prenatal health 
complication (hypertension, n = 2); or labor and delivery complication 
(cesarean birth, n = 26 or maternal hemorrhage/transfusion, n = 5). 
This resulted in 152 women who continued in the study postpartum. Of 
this group, 18% (n = 27) scored symptomatic of depression 
(EPDS ⩾ 10) during the 6-months postpartum. Demographic and 
psychosocial data for the entire group, and for those who did or did 
not score symptomatic of depression, are shown in Table 1. Among 
baseline demographic characteristics, self-report of prior history of 
depression, prenatal EPDS score, and family history of depression 
(p = 0.020, p = 0.033 and p = 0.008, respectively) were significantly 
different in women who scored symptomatic of depression within 6-
months compared to those who did not and thus these variables were 
controlled for in the final predictive model for PPD symptoms. PSS 
scores were also significantly different between groups at every time 
point; however, because they were also highly and positively 
correlated (p < 0.0001) with our primary outcome variable (EPDS 
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scores) across and between all-time points, we did not include PSS in 
the final model. 
Table 1. Demographic and clinical characteristics of women who were not or 
were symptomatic of PPD (⩾10 on EPDS) at any time during the first 6-
months postpartum (mean ± SD). 
 
Symptomatic of PPD in 1st 6 months 
 p-Value 
 No (n = 125) Yes (n = 27) 
Age 29.01(5.44) 28.70(4.29) 0.79 
BMI 23.72(4.21) 24.48(4.58) 0.40 
Marital status: married 80.0% 85.2% 0.51 
Race: caucasian 76.0% 85.2% 0.30 
Higher Income 72.6% 85.2% 0.17 
Personal history of depression 18.4% 37.0% 0.03 
Family history of depression 35.2% 63.0% 0.01 
Prenatal EPDS 4.08(3.35) 6.64(4.60) 0.00 
Percentages for marital status, race and SES do not add to 100% due to missing data. 
3.2. Inflammatory markers 
As shown in Table 2, levels of all cytokines were significantly 
increased after delivery compared to prenatal levels, beginning by 1-
week postpartum and continuing, some throughout the study duration. 
When comparing women who had a score indicating PPD to those who 
were not depressed at any time, cytokine analyses at each time point 
(days 7, 14, months 1, 2, 3 and 6) indicated that only TNFα levels 
were significantly different between groups, with lower TNFα levels 
(p < 0.05) at all time points in women symptomatic of PPD (Table 3). 
There were no differences in any other cytokine or in the ratios of any 
pro- to anti-inflammatory cytokine among women who did or did not 
score symptomatic of depression, although day 14 IL-8/IL-10 ratio 
was marginally higher among those symptomatic of PPD compared to 
those non-symptomatic (p = 0.066). Repeated measures analysis 
indicated that over time, the group symptomatic of depression had 
lower TNF-α (p = 0.009), confirming findings from the cross-sectional 
analysis. Similar trends in repeated measures analyses existed for all 
other cytokines and pro- to anti-inflammatory cytokine ratios, i.e., 
lower individual cytokine levels but higher pro- to anti-inflammatory 
ratios in women symptomatic of PPD. 
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Table 2. Pro- and anti-inflammatory cytokine (pg/ml) levels (mean + SE) 
and cortisol area under the curve (AUC) during the prenatal period through 6-
months postpartum. 
 Prenatal Day 7 Day 14 Month 1 Month 2 Month 3 Month 6 
IL-6 
1.86 3.08∗∗ 1.85 1.93 1.82 2.06∗ 1.73∗ 
(±.20) (±.28) (±.19) (±.21) (±.28) (±.49) (±.18) 
 
IFNγ 
1.71 3.12∗∗ 2.37∗∗ 3.01∗∗ 2.12∗∗ 2.88∗∗ 2.46∗∗ 
(±.16) (±.49) (±.27) (±.38) (±.20) (±.58) (±.36) 
 
TNFα 
5.49 6.27∗∗ 6.22∗∗ 6.84∗∗ 6.30∗∗ 6.85∗∗ 6.95∗ 
(±.29) (±.37) (±.34) (±.37) (±.35) (±.42) (±.52) 
 
IL-1β 
0.52 1.06∗∗ 0.76∗∗ 1.38∗∗ 0.90∗ 0.78∗ 0.81∗ 
(±.07) (±.39) (±.13) (±.49) (±.21) (±.14) (±.18) 
 
IL-10 
7.32 9.72∗∗ 10.19∗ 10.50 11.70 10.87 11.81 
(±1.95) (±2.96) (±4.13) (±3.21) (±4.73) (±3.66) (±3.87) 
 
IL-8 
4.10 6.02∗∗ 6.52∗∗ 5.99∗∗ 5.94∗∗ 5.69∗∗ 5.66∗∗ 
(±.37) (±.22) (±.75) (±.79) (±1.08) (±.76) (±1.02) 
 
Cortisol AUC 
3.29 2.35∗∗ 1.96∗∗ 1.68∗∗ 1.72∗∗ 1.60∗∗ 1.64∗∗ 
(±.09) (±.08) (±.07) (±.06) (±.14) (±.05) (±.09) 
For comparisons against prenatal levels: ∗ indicates p ⩽ 0.05, ∗∗ indicates p ⩽ 0.005. 
Table 3. Pro- and anti-inflammatory cytokines (pg/ml) from day 7 through 6-
months postpartum in women who did or did not score symptomatic of PPD 
(∗p < 0.05). 
 Day 7 Day 14 Month 1 Month 2 Month 3 Month 6 
IL-6 
EPDS < 10 3.13 ± .33 1.93 ± .23 2.03 ± .25 1.91 ± .34 2.21 ± .60 1.82 ± .22 
EPDS > 10 2.45 ± .26 1.51 ± .20 1.47 ± .19 1.44 ± .21 1.12 ± .17 1.35 ± .18 
 
IFNγ 
EPDS < 10 3.38 ± .60 2.49 ± .33 3.21 ± .46 2.08 ± .20 3.01 ± 70 2.61 ± .44 
EPDS > 10 2.00 ± .36 1.78 ± .24 1.83 ± .29 2.30 ± .64 1.86 ± .36 1.87 ± .31 
 
TNF-α 
EPDS < 10 6.65 ± .44∗ 6.57 ± .40∗ 7.22 ± .44∗ 6.65 ± .41∗ 7.31 ± .49∗ 7.50 ± .62∗ 
EPDS > 10 4.62 ± .50 4.68 ± .45 5.10 ± .53 4.81 ± .53 4.54 ± .47 4.64 ± .53 
 
IL-1β 
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 Day 7 Day 14 Month 1 Month 2 Month 3 Month 6 
EPDS < 10 1.15 ± .48 0.83 ± .16 1.38 ± .58 0.99 ± .25 0.79 ± .16 0.89 ± .23 
EPDS > 10 0.68 ± .29 0.44 ± .07 1.31 ± .59 0.39 ± .08 0.47 ± .13 0.46 ± .16 
 
IL-10 
EPDS < 10 11.2 ± .3.7 11.8 ± 5.1 12.2 ± 3.9 13.6 ± 5.8 12.6 ± 4.5 13.9 ± 4.9 
EPDS > 10 3.8 ± .0.8 3.6 ± 0.7 3.4 ± 0.6 3.8 ± 1.2 3.0 ± 0.5 3.3 ± 0.7 
 
IL-8 
EPDS < 10 6.05 ± .26 6.69 ± .93 6.34 ± .97 6.24 ± 1.33 5.91 ± .94 5.96 ± 1.26 
EPDS > 10 6.09 ± .35 6.07 ± .42 4.61 ± .28 4.75 ± 0.26 4.61 ± .32 4.62 ± 0.44 
3.3. Cortisol levels 
Across the days of saliva collections, only during the early 
postpartum period, on day 14, were cortisol levels higher in women 
with PPD (p = 0.015) (Table 4). Cortisol AUC at day 14 was a 
significant predictor of PPD symptoms and the odds of having PPD 
symptoms increased by 82% with a one unit change in Cortisol AUC 
(OR: 1.82, p = 0.025). 
Table 4. Salivary cortisol Area Under the Curve (AUC) in women who were 
not or were symptomatic of depression (EPDS ⩾ 10) at any time through 6-
months postpartum (mean ± SE). 
Time 
Symptomatic of PPD in 1st 6 months 
 p-Value 
No (N = 125) Yes (N = 27) 
Prenatal 3.25(0.09) 3.65(0.27) NS 
Day 7 2.33(0.09) 2.51(0.22) NS 
Day 14 1.89(0.07) 2.36(0.20) 0.015∗ 
Month 1 1.65(0.06) 1.81(0.20) NS 
Month 2 1.58(0.05) 2.45(0.84) NS 
Month 3 1.61(0.06) 1.56(0.09) NS 
Month 6 1.66(0.12) 1.55(0.12) NS 
*p < 0.05. 
3.4. Cytokine–cortisol interactions 
The cytokines IL-6, IL-10, IL-8, and IFNγ tended to show 
substantially different relationship patterns with cortisol AUC in women 
who were symptomatic of depression compared to those non-
symptomatic, peaking at 2-weeks postpartum; these patterns were 
significantly different for IL-6 and IL-10 (Fig. 1). Specifically, in the 
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depressed women, cortisol AUC increased with increasing levels of 
these cytokines; this was not true in the women without depression. 
Instead, in the non-depressed women, there was no relationship 
between any measured cytokine and cortisol AUC. These differences in 
patterns between the two groups were more profound in the first 
weeks after childbirth; any difference between groups disappeared 
gradually after month 1. Lastly, because scrutiny of the cytokine data 
identified some substantial outliers, we conducted a secondary 
analysis of the data, deleting outliers as defined by inter-quartile range 
(IQR) of cytokine ± three standard deviations. Since this did not 
significantly impact our findings, and for the purpose of representing 
all data, Fig. 1 is inclusive of all subjects. 
Fig. 1. Interactions between natural log-transformed cytokine and cortisol 
AUC in women who were and were not symptomatic of PPD at day 14. 
Relationship between cortisol AUC and IL-6 and IL-10 were significantly 
different (p = 0.007 and p = 0.004, respectively) for the two groups while 
they were not significantly different for IL-8 and IFN-γ (p = 0.187 and 
p = 0.274, respectively). 
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To consider the combined effects of cytokines and cortisol on 
predicting symptoms of PPD, a multiple logistic regression model was 
developed that included predictors identified in bivariate analyses 
(e.g., day 14 cortisol AUC, TNF-α, IL-8/IL-10 ratio, IL-6 and IL-10). In 
addition, other baseline characteristics that were different across the 
two groups were included and backward elimination was used to 
identify the final model (Table 5). Neither baseline EPDS scores, 
personal history of depression, nor TNF-α, IL-6, IL-10 or their ratios 
(TNF-α/IL-10, IL6/IL10) were significant in predicting PPD symptoms 
in postpartum women and were discarded from the final model. 
Table 5. Estimates of effects (odds ratios) from multiple logistic regression 
model for predicting PPD symptoms. 
Predictors B S.E. Sig. Exp(B) 
95% C.I. for EXP(B) 
 
Lower Upper 
Depression_famhx(1) −1.217 0.546 .026 .296 .101 .864 
Day14_IL8_IL10_PCytokine_log .406 0.216 .060 1.50 0.984 2.292 
 
Day14_AUC 0.770 0.334 .021 2.160 1.123 4.156 
Constant −2.867 0.782 .000 .057   
As shown in Table 5, the final multiple logistic regression model 
indicated that family history of depression, day 14 IL8/IL10 ratio and 
day 14 cortisol AUC were statistically significant predictors of PPD 
symptoms. Particularly, a unit increase in the IL8/IL10 ratio and a unit 
(1 h) increase in the cortisol AUC resulted in a 1.50 (p = 0.06) and 
2.16 (p = 0.02) times increase in the likelihood of observing 
depressive symptoms in postpartum women respectively. In contrast, 
not having a prior family history of depression resulted in a 45.4% 
(p = 0.03) decrease in observing depressive symptoms. Overall, this 
model correctly classified 84.2% of the participants. Even without 
including a family history of depression, the model correctly classified 
82.5% of individuals. 
4. Conclusions 
Although significant research has been conducted to identify and 
relieve psychosocial risk factors for PPD (Dennis and Dowswell, 2013), 
considering psychosocial risk factors alone continues to leave a large 
amount of variance in risk of PPD unexplained. A growing appreciation 
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of the mind–body connection in health and disease has led to an 
increased focus on biological processes that may underlie or contribute 
to the disorder (Albacar et al., 2010, Binder et al., 2010, Bloch et al., 
2000, Corwin et al., 2003, Costas et al., 2010, Figueira et al., 2010, 
Goshtasebi et al., 2013, Guintivano et al., 2013, Kimmel et al., 2013, 
Le Donne et al., 2012, Maes et al., 2002 and O’Keane et al., 2011). In 
the current study, our primary finding, that variability in the 
functioning of the bi-directional interactions between the immune-
inflammatory response and the HPA axis within the first weeks after 
childbirth influences a woman’s risk of PPD, further emphasizes the 
importance of an integrated PNI response in the postpartum mental 
health continuum. 
Although our original hypothesis was that dysregulation of the 
cytokine/cortisol relationship postpartum would increase a woman’s 
risk of PPD, our data suggest just the opposite: “dysregulation” after 
giving birth may protect women against depressed mood. This paradox 
of high cytokines and low cortisol provides additional support for the 
recognition of pregnancy and the postpartum as physiologically unique 
periods of life characterized by tightly regulated inflammatory states 
(Aagaard-Tillery et al., 2006 and Mor and Cardenas, 2010; Shelton et 
al., 2014). 
The changes in cytokine and cortisol AUC levels after delivery 
compared to levels during the 3rd trimester of pregnancy (Table 2) 
highlight the significant activation of both arms of the immune 
response in the first days and weeks after childbirth. In non-
postpartum individuals, sudden increases in pro-inflammatory 
cytokines similar to those seen immediately after childbirth might be 
expected to increase cortisol secretion (Besedovsky and del Rey, 
2006). However, our data suggest that in healthy women, this 
response is blunted or absent; thus although pro-inflammatory 
cytokines rise following labor and delivery, cortisol levels do not, 
reflecting postpartum HPA axis suppression continuing for at least the 
first 2-weeks after delivery. In contrast, for women who develop 
symptoms of PPD, the cytokine stimulation of cortisol secretion in the 
early postpartum is robust, and negatively impacts mood. We propose 
that these women experience an early postpartum return of 
hypothalamic responsiveness, as suggested by the significantly 
positive interactive effect between cytokines and cortisol in postpartum 
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women who developed significant symptoms of PPD but not in women 
who did not (Fig. 1). 
The data presented in Table 2, showing mean cytokine and 
cortisol AUC levels from the 3rd trimester of pregnancy through 6-
months postpartum are also notable in that they provide for the first 
time, a comprehensive view of PNI activity across approximately 8-
months during this critical pre- to post-natal period (32–36 weeks of 
pregnancy – 6 months postpartum). The significant changes in both 
the innate immune response and the HPA axis during pregnancy and 
the postpartum period highlight the uniqueness of these times in a 
woman’s life (Aagaard-Tillery et al., 2006 and Mor and Cardenas, 
2010). Further investigation of these cytokine profiles over time in a 
larger sample is warranted. 
Although research supporting a direct, positive association 
between markers of inflammation and major depression has been 
identified in a variety of populations, evidence for this linkage in 
pregnant and postpartum women has been inconclusive (Osborne and 
Monk, 2013). In this study, we found that decreased levels of TNF-α 
were associated with symptoms of depression, although when 
considering the ratio of TNF-α/IL-10, this relationship was lost. 
Deceased TNF-α in the depressed women, might also reflect an intact 
cytokine-glucocorticoid feedback circuit in this population, where 
higher levels of cortisol limit further secretion of pro-inflammatory 
cytokines (Pace et al., 2012 and Yang and Glaser, 2002). The 
cytokine-glucocorticoid feedback circuit appears not to be active in 
women who do not develop symptoms of PPD, further suggesting that 
cytokine/cortisol “dysregulation” may be beneficial during this unique 
time. 
The data presented in this also study may partially explain why 
previous studies of the relationship between cytokines and the 
development of PPD have been inconclusive, and why both hyper- and 
hypo-activity of the HPA axis have been linked with risk of PPD. First, 
our data suggest that cytokines and cortisol interact to influence 
mood, and that the timing and sequence of their interactions during 
the postpartum period is critical. In addition, considering the balance 
of pro- to anti-inflammatory cytokines, rather than just individual 
cytokines, appears necessary to uncover the full picture. While pro-
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inflammatory cytokines, such as TNF-α, IFN-γ, IL-1β, and IL-6 
coordinate the non-specific (inflammatory) immune responses, anti-
inflammatory cytokines such as interleukin IL-10 not only provide 
negative feedback to limit inflammation, but also support development 
of a type 2, or specific immune response (Petrovsky and Harrison, 
1997). The findings in this study emphasize the importance of the 
interplay between these two arms of the immune response to affect 
mood, and mirror findings from other studies emphasizing the 
importance of considering pro- to anti-inflammatory cytokine ratios 
when evaluating risks for depression (Bensimon et al., 
2014 and Fredericks et al., 2010). And lastly, the variability in 
previously published findings on inflammation and PPD may be due as 
well to the timing of sample collections, the sources of sample, or the 
inclusion of women with confounding perinatal experiences such as 
surgical birth or transfusion, or co-morbidities known to affect the 
immune system or mood. 
Limitations to this study include a relatively small number of 
participants and reliance on self-report of key variables including pre-
pregnancy body weight and height, affective symptoms, and personal 
and family history of depression. The inclusion of self-report of 
personal and family history of depression may be especially 
problematic since we did not require that answering “yes” to either 
required that they be confirmed by a clinical diagnosis and/or treated 
medically, although some women might have interpreted the question 
that way. Likewise, requiring that all postpartum women must have 
had an uncomplicated, vaginal delivery of a healthy singleton infant, 
and that both mother and infant left the hospital together within 72-h 
of delivery, limits the generalizability of our findings. Lastly, this study 
utilized only indirect evidence of postpartum HPA axis responsiveness. 
Clearly, further investigation of the hypotheses tested in this study is 
needed in order to better understand the underlying mechanisms of 
PPD and to predict and prevent its occurrence in susceptible women. 
In summary, to our knowledge, our study provides the first 
evidence that HPA axis responsiveness to inflammatory mediators in 
the early weeks after delivery significantly increases the risk of PPD. 
By simultaneously collecting and analyzing longitudinal data on 
cytokines and HPA activity we were able to detect an interaction 
between these two systems. It appears that variability in HPA axis 
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responsiveness during the postpartum period may explain why some 
women develop depression when exposed to the inflammatory stimuli 
associated with the childbearing process while others do not. 
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